Artist’s Statement
Alcoholism has always been something that has
intrigued me. I’ve always had trouble thinking of alcoholism as a hereditary
disease, when it appears to be such a self inflicted thing. I thought that by
understanding more about the disease, it would make more sense to me how it is
classified as a disease. Also, I am likely to carry a genetic predisposition to
alcoholism, due to the pattern of alcoholism in my family, which gave me even
more reason to use this for my topic. I wanted to learn about something that
actually affected me, and because me or my siblings might end up struggling with
alcoholism, researching it for my topic seemed like a good choice.
While
doing my initial research on alcoholism, I started to find several articles
about gene therapy for it. For me, gene therapy is really intriguing and this
was the first time I heard about it the potential of using it to treat
alcoholism. The hard thing about alcoholism is that it so far doesn’t have a
direct treatment. To avoid the flu, you get a shot, but there’s obviously no
such thing for alcoholism. If alcoholism runs in your family, all you can really
do is do your best to stay away from alcohol and if you start excessively
drinking, there isn’t really a treatment outside of therapy. As I read about
gene therapy, actually giving the disease a direct cure, I knew instantly that I
was not only to do my project on alcoholism, but instead, focus on gene therapy
for alcoholism and what that would entail.
I had a few goals going into the
project. One was to learn as much as possible about gene therapy for alcoholism.
By the end of the project, I wanted to be an expert on the topic. I also hoped
to simply gain the experience of an in depth research project where I got the
experience of doing my own research and making a finished piece that could sum
up all that I had learn; this finished piece, in the form of an educational
video on gene therapy for alcoholism.
I hope that everyone who sees my film
will be able to walk away with a good understanding of what gene therapy for
alcoholism is. I hope that they will understand the overall process of a gene
therapy and how it relates to alcoholism. I also want the information on the
gene transfer preformed on the rats to really stun the viewer; for them to
realize how close scientists are coming to the treatment. This isn’t some old
issue in science that everything has already been discovered for; this is a
current issue that could affect our futures. All I can ask is that the viewer
will walk away with these similar thoughts in their mind, possibly sparking
their own interest in gene therapy for alcoholism as well.
Last, I would like
to talk about the category I chose. Film is something I’m really interested in,
and I have had previous experience working with film. I also think that the idea
of combining an art medium with science is very cool. Film is a great way to
portray ideas because you get it all; the visual, the sound, the music. Gene
therapy for alcoholism is a huge topic and with so much to say, making a film
seemed like the most effective way to educate people on the subject.
From
working on this project, I ended up learning a lot. I think everyone should take
interest into gene therapy for alcoholism and hopefully my piece will do its job
and allow for this to happen.
Effort Resource Paper
It
is nearly impossible to make an effective film if you don’t put effort into
using the resources around you. For my biotech expo project, an educational film
on the possibility of genetic predispositions to alcoholism, I ended up using a
lot of resources.
For
my research, I did my best to get my hands on as many scientific articles as
possible about my topic. The Internet being the most convenient source, I spent
hours researching gene therapy online. Unfortunately, most of articles on the
topic weren’t available to the public, but with two different trips down to the
UW library, I was able to get all I needed. Some online articles that were
particularly helpful that I accessed at the UW library were “The American
Journal of Human Genetics” by Xingguang Luo, Henry R. Kranzler, Lingjun Zuo,
Shuang Wang, Nicholas J Schork, and Joel Gelerneter and “Toward understanding
the genetics of alcohol drinking through transcriptome meta-analysis” by Megan
K. Mulligan. Although the University of Washington’s health services library
collection of books is small, I managed to find some that were very useful.
These included “The Pathogenesis of Alcoholism- Biological Factors” by Gegamin
Kissin and Henre Begleiter and “The Genetic Basis of Alcohol and Drug Actions”
by Crabbe Jr., John C., and Adron
Harris.
Although
the UW had the most sources on my topic on the molecular level, I got a lot of
information from my Internet at home. Sources such as the “Gene Therapy Reduces
Drinking in Rats with Genetic Predisposition to “Alcoholism”” from Laboratory
News and “Genetic Strategies to Detect Genes Involved in Alcoholism and
Alcohol- Related Traits” by Danielle M. Dick and Tatiana
Foroud.
To
make my film, I used my family’s handy cam and edited it on iMovie, because I
didn’t have access to any other equipment. Both the handy cam and iMovie worked
great, and were a good choice because they were so easily accessible.
I
shot a lot of the footage for my film using animation, which I did simply by
using stop animation. I included some pictures in my film of scientists and
viruses, etc., all which I assessed over the web. My audio consisted of a voice
over I had written and read myself.
For
an additional source I attempted to get an interview with a scientist who has
insights on the issue, but due to awkward timing with vacations, bad weather and
other breaks this never happened. I’m happy with how my piece turned out with
out an interview
though.
My
film opens up with some statistics about alcoholism in the United States, which
I found on the Internet and included to create an intriguing beginning. I also
used a quote by Peter Thanos, PhD, about the gene therapy his lab had conducted
on the
mice.
I
decided that I really wanted to include footage of mice, since I was talking
about them so much, so I drove down to Pet-Co, and filmed the mice there.
For additional footage I used my parents as actors to simply sit there and
sip their
wine.
As
you can see, by accessing so many different resources, I was only then able to
create my film. For the bulk of my research I ended up using the internet as
well as a variety of resources at the UW library. For footage, I used my
parents, the Internet, Pet-Co mice, animation and some footage I shot of
alcohol. To make my film I used the best equipment I had access to, and ended up
having no problem working with either iMovie or my camera.
Research Paper
Potential Gene Therapy for
Alcoholism
Gene
therapy, the replacement of defective genes by transplanting normal genes into
cells, is a new experimental and controversial study in science. It has already
been shown to be a main treatment for monogenic diseases, which are diseases
controlled by a single gene. Recent research has been done concerning the
possibility of treating the common disease, alcoholism, with gene therapy.
Alcoholism is a complicated disease that affects many. More than 18% of
Americans experience alcohol abuse or dependence at some point in their lives
and more than 100,000 people in the US alone die from excessive alcohol
consumption each year, it being a direct or indirect cause. The possibility of a
treatment for this complicated disease through gene therapy has intrigued many
scientists. Alcoholism is estimated to be hereditary 50 to 60% of the time. By
applying gene therapy, people with this genetic predisposition to become
alcoholics could use gene therapy to replace the affected genes that carry the
disease.
Statistics From:
"Office of Applied Studies." U.S. Department of
Health & Human Sevices. 2004. SAMHSA. 9
Feb 2007
<http://www.oas.samhsa.gov/nhsda.htm>.
Most
gene therapy that has been experimented with so far is for monogenic genes.
These genes include skin disease; hemophilia, which is a medical condition where
the blood’s ability to clot is drastically reduced resulting in severe bleeding;
Phenylketonuria, which is the inability to metabolize phenylalanine (an amino
acid) that can cause brain and nerve damage; and muscular dystrophy, a condition
that weakens muscles. Unlike these diseases, alcoholism is a complicated disease
that is caused by potentially many genes as well as environmental factors. To
treat it genetically is much more complicated due to the long list of possible
genes, chemicals, and other problems that may be causing the predisposition.
These include Alcohol dehydrogenises, Aldehyde dehydrogenises,
Gamma-aminobutyric acid A receptors, Mu-opioid receptors, Serotonin transporter,
and Neuropoptide Y and neuropeptide Y receptors. Some of these will be covered
more in depth later on.
As
you can see, there are many options for genes that a gene transfer can be
applied to. The difficult part is identifying the genes that are most involved,
but these genes can vary from case to case. With a disease such as hemophilia,
the new gene is inserted in the blood stream. The genetic material of the gene
allows so that FVII, which is a protein that allows for regular blood clotting,
is produced and stored in blood platelets, hidden from view and attack where it
is released when a blood vessel is damaged, therefore allowing for normal
clotting. This process is much simpler because the disease is monogenic. The new
gene containing the FVII corrects the original gene that lacked it, resulting in
hemophilia. With alcoholism, although the same process would occur, there isn’t
a single gene that is identified as causing the disease, so the transfer becomes
much more
complicated.
This
process described above is that of the actual gene transfer and is important to
understand as a basis of the possibility of gene therapy for correcting
alcoholism. Gene therapy is a process in which a “normal” gene is inserted into
the genome to correct and replace the undesired gene.
The genome is the
whole hereditary information of a living organism and is encoded in the DNA and
the complete DNA sequence of one set of chromosomes. In most cells of the human
body, the genetic information is contained in 46 microscopic structures in the
nucleus called the chromosomes. The first 22 chromosomes are present in pairs
and the 23rd pair consists of either 2 X chromosomes, if female, or and X and Y
chromosome, if male. These chromosomes are inherited from the parents, with each
parent providing one set of the 23 chromosomes. DNA, or deoxyribonucleic acid,
is contained in these chromosomes. This is where these hereditary traits that
gene therapy targets are found. So, to replace an undesired gene requires the
new gene to be inserted into this genome.
The new gene must be carried in
order for the gene to be substituted, which happens through a carrier molecule
known as a vector. The vector is some type of virus. The virus is tested and
proved harmless, so it acts solely as a vector, causing the subject no harm.
Often, scientists genetically alter the viruses’ own DNA to prevent it from
causing the subject harm and have been tested to be used for gene therapy. The
virus is capable of enclosing something and delivering their genes to human
cells, a unique trait that perfectly serves gene therapy. Although this
capability usually is what causes sickness, such as HIV, TMV, or smallpox,
scientists have been able to use this capability for delivering the genes they
want to replace the defective genes with. The point is to remove the disease
causing genes and replace them with beneficial ones.
These types of virus
vectors include the retrovirus, adenoviruses, herpes simplex virus and
adeno-associated viruses. However, other non-viral methods exist as well. The
regular virus is the most common method. A virus attacks their host and
introduces their genetic material into the host cell as part of their
replication cycle. The viruses’ genetic material contains basic instructions on
how to make more copies of these viruses, using the body’s normal production
machinery to serve the needs of the virus. The host cell that contains the virus
will carry out these instructions as well as produce more copies of the virus,
so that more cells would be infected. Some types of viruses insert their genes
into the subject’s genome. This process does not have to have a negative effect,
as scientists discovered. By inserting good genes into the virus, the virus then
carries the desired gene into the subject’s genome. There, the genetic
instructions encoded in the virus allow the gene to replicate and replace the
undesired gene. By the replication of the healthy genes in the genome, the
healthy gene should dominate over the unhealthy one and take over and use the
host’s production machinery, this time, having a positive effect.
The
retrovirus is a class of viruses that are capable of creating double-stranded
DNA copies of their RNA (a chemical similar to DNA form which proteins are made)
genomes. These copies of its genome can be integrated into the chromosomes of
host cells. An example is HIV. An adenovirus is a class of viruses with
double-stranded DNA genomes. They cause respiratory, intestinal, and eye
infections in humans and the common cold. The herpes simplex virus is a class of
double-stranded DNA viruses that infect the neutrons. An example is herpes
simplex virus type 1, which is a common human virus that causes cold sores.
Last, the adeno-associated virus is a class of small, single stranded DNA
viruses that can insert their genetic material at a specific site on chromosome
19.
To
summarize, scientists take a virus and alter its genetic material to remove the
negative effects of the virus and add the desired gene. The virus is inserted
into the genome, sometimes into the cell membrane where it then finds its way
into the genome where it then multiplies the desired gene and then replaces the
undesired gene. If the virus is an adeno virus, the vector, containing the
modified DNA, is inserted into the cell. The cell membrane mistakes the virus
for a protein, so it is let into the cell undetected. It then travels through
until it reaches the genome, inside of the nuclear envelope, where the cells
replicate, and creating more of the desired
gene.
This
overview was of the basic gene transfer, which consists of the same methods no
matter which gene is being altered. What causes the continuous research
scientists have been putting forth onto the subject is identifying the specific
gene to be altered. Monogenic diseases require identifying the single gene
affected. Although the effect from patient to patient is the result of
alcoholism, different combinations of their genes as well as environmental
factors can lead one to become an alcoholic. Environmental factors are what can
cause of contribute to alcoholism, but aren’t hereditary, but instead gained
from the subject’s surroundings. Once the gene or genes affecting the specific
patient are identified, this process can be used to alter the patient’s genes.
Gene
therapy for alcoholism is most effective when there is one main gene affecting
the disease. Alcoholism is monogenic, because of the long list of genes as well
as environmental factors that can create it. However, an individual only has to
contain one of these infected genes to have a predisposition to alcoholism. When
a subject has one gene that is the primary cause of their disease, treatment
through gene therapy will be more
effective.
The
science of gene therapy also raises some important ethical issues that should be
discussed. Gene therapy has provided technology to fix many disorders and
diseases, but is not yet declared legal to perform on humans. To many, gene
therapy The fear around gene therapy is that if could ultimately be used
to create the “perfect” human. Science isn’t limited to correcting only those
genes that carry predispositions to diseases. Gene therapy can theoretically
alter any gene, influencing things such as eye color, shape, size, color,
disabilities, and diseases. Our genes are what make us unique and it is a common
fear that gene therapy could take this away. Many don’t support the research of
the therapy is debated, due to the time and money it takes up.
On
the other side of the argument, gene therapy could act as a cure for many
diseases. Hereditary diseases that have been proven to be prevented and diseases
such as alcoholism can be avoided. Although many people fear that even these
therapeutic gene therapy treatments may change human nature, this is not true.
It also holds potential to helping correct disabilities. Gene therapy, when used
right can be a positive thing. However, the concern of all the ways it could be
misused have caused much worry as to all the research that is being conducted
for it.
As
it has been mentioned, many studies have been done to identify the genes that
carry the disease alcoholism, which is often the most complicated part of gene
therapy. It has been difficult to detect every involved gene, for this
particular disease is not monogenic. The potential genes discovered so far have
already been listed, but it is important to understand what these genes are and
how they affect alcoholism.
Alcohol
dehydrogenase, or ADH is a group of dehydrogenase enzymes that occur in many
organisms and assist the connection between alcohols and aldehydes (an organic
compound formed by alcohol oxidation) or keytones (an organic compound made by
oxidizing alcohols.) Oxidation when referring to alcohol is usually the
conversion to these aldehydes and keytones, both which contain a carbonyl group-
a carbon- oxygen double bond. They serve to break down alcohols, which could
otherwise be toxic. It allows for the consumption of alcoholic beverages but
also breakdown the alcohols naturally contained in foods or produced by
bacteria. How high or low the level of alcohol dehydrogenase is effects ones
level of response to alcohol. A mutation that scientist found in some people was
a higher level of response and therefore a higher level of alcohol
dehydrogenase, but actually decreasing ones risk of becoming an alcoholic. This
means if the desired, but in fact mutated gene was to replace the subject’s gene
containing their current level of alcohol dehydrogenase, they would be less
prone to
alcoholism.
Aldehyde
dehydrogenase, or ALDH are a group of enzymes that causes the oxidation of
aldehyde, an organic compound formed by the oxidation of alcohols. ALDH oxidizes
ethanol to acetaldehyde, which causes the “hangover.” High levels have about the
same effect as alcohol dehydrogenase, for the two are believed to be closely
linked. Those who have a high level suffer from the alcohol-flush reaction when
they drink alcohol beverages, which have unpleasant symptoms that usually reduce
alcohol consumption, reducing the risk of alcoholism. By adding this high level
in, the subject with experience these unpleasant symptoms when they consume
alcohol and are much more likely to refrain from alcohol abuse.
Gamma-aminobutyric
acid (GABA) A receptors are neurotransmitter receptors located in the brain. It
acts at restrained synapses in the brain. A synapses is a junction between two
nerve cells, consisting of a minute gap across which impulses pass by diffusion
(spreading out) of a neurotransmitter, a chemical substance released at the end
of a nerve fiber. The receptors are believed to mediate a number of alcohol’s
behavioral actions. The subunit composition of GABA receptors determines
behavioral sensitivity to alcoholism, depending on what subunits are present.
This means that certain subunits in the gene cause different behavioral actions
such as loss of reflex in the patient, which are likely to decrease the risk of
the disease. Gene therapy can be preformed in the brain to replace the current
subunits with different ones, by transporting the genetic instructions that
create the subunits into some of the brain’s cells.
ALDH and GABA
Information:
Luo,
Xingguang, Henry R. Kranzler, Lingjun Zuo, Shuang Wang, Nicholas J.
Schork, Joel Gelernter.
"Diplotype Trend Regression Analysis of the ADH
Gene Cluster and the ALDH2
Gene: Multiple Significant Associations with
Alcohol Dependance." The
American Journal of Human Genetics 11 Jun
2006 03 Dec @006
<http://www.pubmedcentral.nih.gov/articlerender.fcgi?
tool=pubmed&pubmedid=16685648>.
These
are three of the genes that have been identified to contribute to an
individuals’ risk of becoming an alcoholic. There are more genes that have been
discovered beyond these three. Alcoholism can result from a combination of
contributing genes as well as environmental factors. These genes don’t directly
carry the genetic trait of a tendency towards alcohol dependence, but control
other behavioral genetic traits that predispose someone to become an alcoholic.
To
identify these genes involved in alcoholism, investigators search entire genetic
material. This is done by testing for linkage between polymorphic markers, or
the location of mutated genes that lead to the disease and the behavior of the
alcoholic. Families with several affected members are studied to find whether
specific alleles (one or two alternative forms of a gene that are a result of a
mutation) are found at the same place on a chromosome. By using markers spaced
evenly along all the chromosomes, scientists will analyze entire genomes. This
therefore can identify vulnerable genes, even with no prior knowledge of the
gene. This method has been used to identify genes of many different diseases,
but scientists are still working on identifying all the genes relating to
alcoholism.
Although
it is possible that not all genes will be discovered that effect alcoholism
using linkage studies, many other methods exist. Another widely used method for
testing for genetic predisposition to alcoholism is that of twin studies. Twins
contain much of the same genes. In a study of an adult pair of Australian twins,
the heritability of alcoholism was estimated to be 42-75% in men and 51-65% in
women. The comparison of twin DNA has resulted in what is believed as accurate
results to the predisposition. Twin studies allow scientists to separate
hereditary factors from environmental factors. Scientist could compare the genes
of twins and, depending on the outcome of which twins got the disease, study
what possible genes cause this, or if these genes were the same and only one
twin became addicted, what were the environmental factors
instead.
Recent
studies have been conducted using rats as test patients to perform actual gene
therapy on. Scientists in US Department of Energy’s Brookhaven National
Laboratory in Longview, New York have used the technique of gene therapy to cut
down drinking in rats with a genetic predisposition to alcoholism. What made
this study more effective then past studies that could also be mentioned was
that the rats already had the genetic predisposition to alcoholism instead of
being trained to drink. The alcohol preferring rats preferred five times more
grams of alcohol per kilogram of body weight per day when given a free choice
between that and water while the other rats preferred the water. Both groups
were then treated with a gene transfer to increase level of brain dopamine
receptors, a chemical important for transmitting feelings of pleasure and reward
that has been proven to play a role in alcohol dependence. The gene administered
was for dopamine D2 receptors (a protein relevant to alcohol dependence.) The
rats had low levels of dopamine D2 receptors, 20-25% lower levels then that of
the non-preferring rats. This lead to reward deficiency syndrome, a common
syndrome that predisposes some to addictive behavior. The harmless virus was
inserted directly into the rats’ nucleus accumbens, which is the brains pleasure
center. The virus then traveled into the brain cells genome where it used the
genetic instructions to increase the making of D2 receptor proteins.
The
results showed that the alcohol-preferring rats exhibited a 37% reduction in
alcohol preference, cutting their total alcohol consumption in half. It went
from 2.7 grams per kilogram to 1.3 grams per kilogram. The non-preferring rats
also reduced their drinking, but not nearly as drastic. “These findings further
support our hypothesis that high levels of D2 are casually associated with a
reduction in alcohol drinking and may serve as a protective factor against
alcoholism.” – Peter Thanos, as quoted by:
"Gene Therapy Reduces Drinking in Rats with Genetic
Predisposition
to "Alcoholism"." Laboritory News. 05 May 2004. 6 Dec
2006 <http://www.bnl.gov/bnlweb/pubaf/pr/PR_display.asp?prID=04-47>.
Chronic drinking is associated with decreased
dopamine levels because these chronic drinkers will use alcohol to increase
immediate brain production of dopamine. My increasing these levels through gene
therapy, drinkers lose there reason to drink.
A problem with most gene
transfers is that they don’t last that long due to the immune system fighting of
the multiplication of the gene, which the body sees as a virus. Viruses such as
HIV remain a lifetime, so extending the life span of the gene transfer should
one day be possible. With the rats, the rats’ consumption returned to
pretreatment after twenty days and the greatest reduction in their drinking
occurred after day two.
As
you can see, scientists are constantly making advancements towards using gene
therapy to treat alcoholism. The study conducted at the Brookhaven National
Laboratory was a huge step towards being able to apply the treatment to human
patients.
In conclusion, gene therapy for alcoholism is an important issue
in the science world that is constantly being developed. The many different
genes and environmental factors that contribute to the disease have made this
particular treatment challenging to reach. Although gene therapy is not
yet legal to use on humans, it is developed and studied by scientists everyday.
The potential to have such a direct treatment for such a common and often deadly
disease motivate scientists to continue to conduct research. In time, scientists
hope to discover all involved gene that lead to the hereditary disease as well
as determine them on a case-to-case basis. Who knows what the future has in
store for gene therapy for alcoholism, but scientists’ hopes are
high.
Bibliography
"Gene Therapy Reduces
Drinking in Rats with Genetic Predisposition
to "Alcoholism"." Laboritory
News. 05 May 2004. 6 Dec 2006 <http://www.bnl.gov/bnlweb/pubaf/pr/PR_display.asp?prID=04-47>.
Article
about research done at the U.S. Department of Energy’s Brookhaven National
Laboratory. Scientists performed successful gene therapy on alcohol preferring
rats.
"Gene Therapy - An Overview." Access
Excellence. 1990. The National
Health
Museum.
2 Dec 2006 <http://www.accessexcellence.org/RC/AB/BA/
Gene_Therapy_Overview.html>.
This
article is an overview of the process of gene therapy. Also contains information
about what make a disease treatable through gene
therapy.
Mulligan, Megan K.. "Toward understanding the
genetics of alcohol drinking
through transcriptome
meta-analysis." 17 Apr 2006 03 Dec 2006
<http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&
pubmedid=16618939>.
Article
about the use of rodents models to approach the molecular complexities that
cause the predisposition to alcoholism.
"Gene Therapy."
Human Genome Project Information. 6 Dec 2006
<http://www.ornl.gov/sci/techresources/Human_Genome/medicine/
genetherapy.shtml>.
Explores
gene therapy for four different types of viruses (Retroviruses, Adenoviruses,
Adeno-associated viruses, and Herpes simplex virus.) Talks about constricting
factors of why it is not yet used for treatment of diseases.
"Gene Therapy."
Wikipedia. 04 Dec 2006. 6 Dec 2006
<http://en.wikipedia.org/wiki/Gene_Therapy>.
Contains
background information about gene therapy as well as the basic process and an in
depth analysis of different vectors.
Gaspar, H. Bobby.
"Successful reconstitution of immunity in ADA-SCID by stem
cell
gene therapy following cessation of PEG-ADA and use of mild preconditioning.."
Mol Ther. 14 Oct 2006 04 Dec 2006 <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16905365&query_hl=10&itool=pubmed_docsum>.
This
is a scientific article that contains case information on the treatment of
monogenic disease and successful vectors.
Lobos González,
Lorena, Carlos Muñoz and Brauning, Amalia and Sapag.
"Ribozymes:
towards gene therapy for alcoholism by silencing the mRNA
for
mitochondrial aldehyde dehydrogenase (ALDH2)." ISBRA 2006
World
Congress on Alcohol Research (2006) 04 Dec 2006
<http://www.isbra2006.com/abstract/296.html>.
An
analysis of mammalian tissues, which is being applied to dissect molecular
mechanisms that contribute to alcoholic liver
disease.
Kissin, Gegamin, Henri Begleiter. The
Pathogenesis of Alcoholism- Biological
Factors. 7. New
York: Plenum Press, 1983.
A print journal which addresses the
genetic factors in alcoholism and identifying then from environmental factors.
Thoroughly explores both linkage and twin studies.
Crabbe
Jr., John C., Adron Harris. The Genetic Basis of Alcohol and Drug
Actions. 1. New York: Plenum Press, 1991.
This
is a scientific book that addresses behavioral studies of genetic differences in
alcohol action and preference drinking in rodents.
Luo,
Xingguang, Henry R. Kranzler, Lingjun Zuo, Shuang Wang, Nicholas J.
Schork, Joel Gelernter.
"Diplotype Trend Regression Analysis of the ADH
Gene Cluster and the ALDH2
Gene: Multiple Significant Associations with
Alcohol Dependance." The
American Journal of Human Genetics 11 Jun
2006 03 Dec @006
<http://www.pubmedcentral.nih.gov/articlerender.fcgi?
tool=pubmed&pubmedid=16685648>.
An
in depth article focusing on the genes discovered so far to cause genetic
predispositions to alcoholism. Also addresses linkage
studies.
Dick, Danielle M., Tatiana Foroud.
"Genetic Strategies to Detect Genes Involved
in
Alcoholism and Alcohol- Related Traits." Alcohol Research & Health
2603 Nov
2002 172-180. 29 Nov 2006
<pubs.niaaa.nih.gov/publications
/arh26-3/172-180.pdf
->.
Thoroughly explained article addressing three main methods
of discovering genes that may cause a predisposition to alcoholism. These
include linkage studies, twin studies, and rodent test models. It explains how
each of the methods can help to discover involved genes.
"Office of
Applied Studies." U.S. Department of Health & Human Sevices. 2004.
SAMHSA.
9 Feb 2007 <http://www.oas.samhsa.gov/nhsda.htm>.
Statistics
concerning alcoholism in the United States.
on
2/16/07 4:18 PM, Jeanne Chowning at jchowning@nwabr.org
wrote:
I have a quicktime movie but no written materials.
Jeanne Ting Chowning, MS
Education Director
Northwest Association for Biomedical Research
100 W Harrison, North Tower, Suite 430
Seattle, WA 98119
ph 206-957-3337
fx 206-282-2214
jchowning@nwabr.org
www.nwabr.org <http://www.nwabr.org>
From: Barbara Steffens [mailto:barbara.steffens@shorelineschools.org]
Sent: Friday, February 16, 2007 4:03 PM
To: Jeanne Chowning
Subject: Just tried to send again
I sent the file as part of email and it did not send. I also sent the movie file as an attachment by itself and it also would not send./
Viruses are such a pain!
Did the one’s Samantha sent herself come through> ??
Barb
-- Barbara Steffens
Science Teacher
Co-Class advisor 2007
Room F2, Shorecrest High School, 15343 25th Ave NE, Shoreline, WA 98155
[ This message (including any attachments) contains confidential information
intended for a specific individual and purpose, and is protected by law. If
you are not the intended recipient, you should delete this message and are
hereby notified that any disclosure, copying, or distribution of this
message, or the taking of any action based on it, is strictly prohibited. ]